Risperidone and tardive dyskinesia in organic psychosis [1]

Pharmacopsychiatry

Volumn 31, Issue 2, 1998, Pages 70-71

  Fischer, P ^a,b   Tauscher, J ^a   Kufferle B ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b University Hospital for Psychiatry   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADULT; AGED; ALZHEIMER DISEASE; CASE REPORT; DRUG EFFECT; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; LEWY BODY; MALE; ORGANIC BRAIN SYNDROME; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

EID: 0031942107     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979302     Document Type: Letter

References (9)

1. Lee, H., J. M. Cooney, B. A. Lawlor: The use of risperidone, an atypical neuroleptic, in Lewy body disease. International Journal of Geriatric Psychiatry 9 (1994) 415-417
2. Janssen Pharmaceutica: Risperidone monograph. Oxford: Oxford Clinical Communications 1993.
3. Chouinard, G.: Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study. Journal of Clinical Psychopharmacology 15 (1995) 36S-44S
4. Woerner, M. G., B. B. Sheitman, J. A. Lieberman, et al.: Tardive Dyskinesia induced by Risperidone. Am. J. Psychiatry 153 (1996) 843
5. Daniel, D. G., K. Smith, T. Hyde, et al.: Neuroleptic-induced tardive dyskinesia. Am. J. Psychiatry 153 (1996) 734
6. Buzan, R. D.: Risperidone-induced tardive dyskinesia. Am. J. Psychiatry 153 (1996) 734-735
7. Addington, D. E., J. A. Toews, J. M. Addington: Risperidone and tardive dyskinesia: a case report. Journal of Clinical Psychiatry 56 (1995) 484-485
8. Jeste, D. V., M. P. Caligiuri: Tardive dyskinesia. Schizophrenia Bulletin 19 (1993) 303-315
9. Kane, J. M.: Tardive dyskinesia: epidemiological and clinical presentation. In: Psychopharmacology: The Fourth Generation of Progress (Eds.: Bloom, F. E., D. T. Kupfer) Raven Press, New York (1995) 1485-1495